 |
|
|
Patients will be provided with and begin using the FDA-approved devices in January. (Photo courtesty of InterVRx) |
UMass Medical School’s Clinical Pharmacy Services has partnered with InterVRx to review the accuracy, completeness and usability of specialty drug clinical protocols used within its patient monitoring platform.
Clinical Pharmacy Services will support the InterVRx Professional Policy Review Committee overseeing specialty drug clinical protocols. Review of protocols will include obtaining input from clinical pharmacist and specialist physicians.
To manage the complex care of patients on specialty drugs, InterVRx has developed automated specialty drug clinical protocols as part of its patient monitoring and management solution. Patient data is collected in real-time from FDA-approved devices and lab results, then measured against clinical protocols to determine effectiveness, patient safety, adherence and clinical outcomes.
The technology includes a mobile application that engages patients and provides them with medication reminders and testing alerts, as well as the ability to enter data on side effects. Health professionals can monitor the data in real time and intervene to assist patients and their providers.
“InterVRx is honored to be partnering with UMass Medical School Clinical Pharmacy Services,” said InterVRx CEO Mark Steck, PharmD, MBA. “By providing scientific research guidance and reviews by academic specialists across a spectrum of specialty drugs and conditions, UMass Medical School will help to solidify the credibility of the evidence-based specialty drug clinical protocols developed by InterVRx.”
The Clinical Pharmacy Services team includes more than 60 clinical pharmacists, as well as pharmacy technicians, data analysts and operational support staff with backgrounds in academia, direct patient care and managed care programs.
“UMass Medical School is eager to begin working with InterVRx to support development of its specialty drug clinical protocols,” said UMass Medical School’s Clinical Pharmacy Services Executive Director Timothy Cummins, MBA, BS, RPh. “The depth and breadth of our clinical experience, as well as our academic ties, are sure to enhance the InterVRx patient monitoring platform.”
